- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Medical Home Fails to Prove Quality, Cost Claims
Although highly touted, the patient-centered medical home model failed to lower use of services or total costs and produced little quality improvement over three years, research has found.
Although highly touted, the patient-centered medical home model failed to lower use of services or total costs and produced little quality improvement over three years, research in the latest Journal of the American Medical Association (JAMA) has found.
However, a number of factors may account for the findings and suggest that medical homes may need “further refinement.”
The research tracked the southeastern Pennsylvania Chronic Care Initiative in one of the first, largest and longest-running multi-payer trials of the team-based model from 2008 to 2011. The pilot included 32 primary care practices with recognition from the National Committee for Quality Assurance (NCQA) and six health plans, with two commercial and two Medicaid plans supplying claims data.
Medical home efforts have encouraged primary providers to invest in patient registries, use electronic medication prescribing, enhanced access options and other structural changes aimed at improving patient care in exchange for bonuses.
Read the full story here: http://bit.ly/NCReps
Source: Healthcare Payer News
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
